224 related articles for article (PubMed ID: 21410324)
21. Supraglottic Atomization of Surfactant in Spontaneously Breathing Lambs Receiving Continuous Positive Airway Pressure.
Milesi I; Tingay DG; Lavizzari A; Bianco F; Zannin E; Tagliabue P; Mosca F; Ventura ML; Rajapaksa A; Perkins EJ; Black D; Di Castri M; Sourial M; Pohlmann G; Dellaca' RL
Pediatr Crit Care Med; 2017 Sep; 18(9):e428-e434. PubMed ID: 28742723
[TBL] [Abstract][Full Text] [Related]
22. Suitability of caspofungin for aerosol delivery: physicochemical profiling and nebulizer choice.
Wong-Beringer A; Lambros MP; Beringer PM; Johnson DL
Chest; 2005 Nov; 128(5):3711-6. PubMed ID: 16304338
[TBL] [Abstract][Full Text] [Related]
23. Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injury.
Schermuly RT; Günther A; Weissmann N; Ghofrani HA; Seeger W; Grimminger F; Walmrath D
Am J Respir Crit Care Med; 2000 Jan; 161(1):152-9. PubMed ID: 10619813
[TBL] [Abstract][Full Text] [Related]
24. Aerosolization of perfluorocarbons during mechanical ventilation: an in vitro study.
Gregor T; Schmalisch G; Burkhardt W; Proquitté H; Wauer RR; Rüdiger M
Intensive Care Med; 2003 Aug; 29(8):1354-60. PubMed ID: 12698244
[TBL] [Abstract][Full Text] [Related]
25. Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial.
Cummings JJ; Gerday E; Minton S; Katheria A; Albert G; Flores-Torres J; Famuyide M; Lampland A; Guthrie S; Kuehn D; Weitkamp JH; Fort P; Abu Jawdeh EG; Ryan RM; Martin GC; Swanson JR; Mulrooney N; Eyal F; Gerstmann D; Kumar P; Wilding GE; Egan EA;
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33060258
[TBL] [Abstract][Full Text] [Related]
26. Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.
Howe C; Hindle M; Bonasera S; Rani V; Longest PW
J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):57-70. PubMed ID: 32758026
[No Abstract] [Full Text] [Related]
27. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
Schermuly R; Schmehl T; Günther A; Grimminger F; Seeger W; Walmrath D
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):445-53. PubMed ID: 9279222
[TBL] [Abstract][Full Text] [Related]
29. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
30. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols.
Alexander BD; Winkler TP; Shi S; Dodds Ashley ES; Hickey AJ
Pharm Dev Technol; 2011; 16(6):577-82. PubMed ID: 21699390
[TBL] [Abstract][Full Text] [Related]
31. Imaging the postdeposition dispersion of an inhaled surfactant aerosol.
Corcoran TE; Thomas KM; Garoff S; Tilton RD; Przybycien TM; Pilewski JM
J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):290-6. PubMed ID: 22393908
[TBL] [Abstract][Full Text] [Related]
32. Experimental Evaluation of Perfluorocarbon Aerosol Generation with Two Novel Nebulizer Prototypes.
Aramendia I; Fernandez-Gamiz U; Lopez-Arraiza A; Rey-Santano C; Mielgo V; Basterretxea FJ; Sancho J; Gomez-Solaetxe MA
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30621300
[TBL] [Abstract][Full Text] [Related]
33. Controlling the droplet size of formulations nebulized by vibrating-membrane technology.
Beck-Broichsitter M; Knuedeler MC; Seeger W; Schmehl T
Eur J Pharm Biopharm; 2014 Aug; 87(3):524-9. PubMed ID: 24657823
[TBL] [Abstract][Full Text] [Related]
34. The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the delivery of pumactant for inhalation therapy.
Young PM; Thompson J; Woodcock D; Aydin M; Price R
J Aerosol Med; 2004; 17(2):123-8. PubMed ID: 15294062
[TBL] [Abstract][Full Text] [Related]
35. Exogenous surfactant replacement: how to deliver it?
Biban P; Chini L; Bonetti P; Sacco F; Zaglia F; Santuz P
Acta Biomed; 2012; 83 Suppl 1():27-32. PubMed ID: 23029874
[TBL] [Abstract][Full Text] [Related]
36. Experimental and Numerical Modeling of Aerosol Delivery for Preterm Infants.
Aramendia I; Fernandez-Gamiz U; Lopez-Arraiza A; Rey-Santano C; Mielgo V; Basterretxea FJ; Sancho J; Gomez-Solaetxe MA
Int J Environ Res Public Health; 2018 Feb; 15(3):. PubMed ID: 29495619
[TBL] [Abstract][Full Text] [Related]
37. Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization.
Nasr M; Nawaz S; Elhissi A
Int J Pharm; 2012 Oct; 436(1-2):611-6. PubMed ID: 22842623
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin.
Calkovska A; Some M; Linderholm B; Curstedt T; Robertson B
Pulm Pharmacol Ther; 2008; 21(2):393-400. PubMed ID: 18032077
[TBL] [Abstract][Full Text] [Related]
39. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
40. Optimized aerosol delivery to a mechanically ventilated rodent.
MacLoughlin RJ; Higgins BD; Laffey JG; O'Brien T
J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):323-32. PubMed ID: 19415985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
